Quantification of cefuroxime and flucloxacillin in synovial tissue and bone using ultra-performance convergence chromatography-tandem mass spectrometry by Bahmany, S., Holst, A., Hoogendoorn, M.H., Oosterhoff, M., van Oldenrijk, J., Bos, P.K., Veltman, E.S., Koch, B.C.P.

Get full text

Sex-specifics of ECT outcome by Blanken, M.A.J.T., Oudega, M.L., Hoogendoorn, A.W., Sonnenberg, C.S., Rhebergen, D., Klumpers, U.M.H., Van Diermen, L., Birkenhager, T., Schrijvers, D., Redlich, R., Dannlowski, U., Heindel, W., Coenjaerts, M., Nordanskog, P., Oltedal, L., Kessler, U., Frid, L.M., Takamiya, A., Kishimoto, T., Jorgensen, M.B., Jorgensen, A., Bolwig, T., Emsell, L., Sienaert, P., Bouckaert, F., Abbott, C.C., Péran, P., Arbus, C., Yrondi, A., Kiebs, M., Philipsen, A., van Waarde, J.A., Prinsen, E., van Verseveld, M., Van Wingen, G., ten Doesschate, F., Camprodon, J.A., Kritzer, M., Barbour, T., Argyelan, M., Cardoner, N., Urretavizcaya, M., Soriano-Mas, C., Narr, K.L., Espinoza, R.T., Prudic, J., Rowny, S., van Eijndhoven, Ph, Tendolkar, I., Dols, A.

Get full text

Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trial by Seefat, M.R., Stege, C.A.M., Lissenberg-Witte, B.I., Levin, M.D., Timmers, G.J., Hoogendoorn, M., Ypma, P.F., Klein, S.K., Velders, G.A., Westerman, M., Strobbe, L., Durdu-Rayman, N., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Dijk, A.C., Koster, A., Silbermann, M.H., van der Spek, E., Beeker, A., Erjavec, Z., de Graauw, N.C.H.P., Leys, M.B.L., Sonneveld, P., van de Donk, N.W.C.J., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Zweegman, S.

Get full text

Treating infections with ionizing radiation: a historical perspective and emerging techniques by van Dijk, B., Lemans, J. V. C., Hoogendoorn, R. M., Dadachova, E., de Klerk, J. M. H., Vogely, H. C., Weinans, H., Lam, M. G. E. H., van der Wal, B. C. H.

Get full text

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV) by Seefat, M.R., Stege, C.A.M., Timmers, G.J., Levin, M.D., Hoogendoorn, M., Ypma, P.F., Nijhof, I.S., Velders, G.A., Strobbe, L., Durdu-Rayman, N., Westerman, M., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Beeker, A., Koster, A., Dijk, A.C., van de Donk, N.W.C.J., van der Spek, E., Leys, M.B.L., Silbermann, M.H., Groen, K., van der Burg-de Graauw, N.C.H.P., Sinnige, H.A.M., van der Hem, K.G., Levenga, T.H., Bilgin, Y.M., Sonneveld, P., Klein, S.K., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Lissenberg-Witte, B.I., Zweegman, S.

Get full text

PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT: RESULTS FROM THE HOVON‐109 STUDY by Straten, L., Hosnijeh, F., Straten, L., Kater, A.P., Oers, M.H., Posthuma, W.F., Chamuleau, M.E., Nijland, M., Hoogendoorn, M., De Croon, F., Wittebol, S., Kerst, J., Marijt, E.W., Raymakers, R.A., Koene, H.R., Dobber, J.A., Tonino, S.H., Kersting, S.S., Langerak, A.W., Levin, M.

Get full text

PS1141 PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT; RESULTS FROM THE HOVON‐109 STUDY by Hosnijeh, F. Saberi, Kater, A.P., Oers, M.H., Posthuma, W.F., Chamuleau, M.E., Nijland, M., Doorduijn, J.K., Gelder, M., Hoogendoorn, M., De Croon, F., Wittebol, S., Kerst, M., Marijt, E.W., Raymakers, R.A., Koene, H.R., Schaafsma, M.R., Dobber, J.A., Tonino, S.H., Kersting, S.S., Langerak, A.W., Levin, M.‐D.

Request full text

The effect of oxygen on the growth and acid production of Streptococcus mutans and Streptococcus sanguis by Beelen, P., Hoeven, J.S., Jong, M.H., Hoogendoorn, H.

Get full text

The effect of oxygen on the growth and acid production of Streptococcus mutans and Streptococcus sanguis by van Beelen, P., van der Hoeven, J.S., de Jong, M.H., Hoogendoorn, H.

Get full text